Calculating accurate IOL power in infants

Article

Intraocular lens (IOL) power, following primary lens implantation in infants, can be calculated reasonably accurately using current formulae, according to a report published online (December 2006) ahead of print in the British Journal of Ophthalmology.

Intraocular lens (IOL) power, following primary lens implantation in infants, can be calculated reasonably accurately using current formulae, according to a report published online (December 2006) ahead of print in the British Journal of Ophthalmology.

Jane Ashworth and colleagues from the Manchester Royal Eye Hospital, UK, conducted a retrospective case review of 25 patients (eight with bilateral cataracts and 17 with unilateral) who underwent cataract surgery with primary IOL implantation at less then 12 months of age. The outcomes measured were actual early-postoperative refraction, lens power calculation error, myopic shift and refractive outcome.

In 83% of cases, actual postoperative refraction was within 2 D of target refraction. The researchers found that lens power calculation error did not depend on axial length, age at surgery or target refraction. The mean myopic shift was 5.43±3.7 D in the first 12 months following surgery, but was significantly greater where surgery was performed at less than 10 weeks of age.

The researchers found that, using current formulae, IOL power can be calculated with reasonable accuracy.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.